These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1752476)

  • 1. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.
    Playford RJ; Batten JJ; Freeman TC; Beardshall K; Vesey DA; Fenn GC; Baron JH; Calam J
    Gut; 1991 Nov; 32(11):1396-400. PubMed ID: 1752476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice.
    Freeman TC; Playford RJ; Quinn C; Beardshall K; Poulter L; Young J; Calam J
    Gut; 1990 Nov; 31(11):1318-23. PubMed ID: 2253919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of misoprostol on gastric acid and mucus secretion in man.
    Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of inflammation and atrophy on pancreatic secretory trypsin inhibitor levels within the gastric mucosa.
    Playford RJ; Hanby AM; Quinn C; Calam J
    Gastroenterology; 1994 Mar; 106(3):735-41. PubMed ID: 7509764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair.
    Marchbank T; Freeman TC; Playford RJ
    Digestion; 1998; 59(3):167-74. PubMed ID: 9643675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats.
    Konturek PCh; Brzozowski T; Konturek SJ; Taut A; Pierzchalski P; Elia G; Pajdo R; Yagi S; Hahn EG
    Regul Pept; 1998 Oct; 77(1-3):95-103. PubMed ID: 9809802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of misoprostol on gastric pepsin secretion and human mucosal cell loss in man.
    Quadros E; Wilson DE
    J Assoc Acad Minor Phys; 1990; 1(2):17-9. PubMed ID: 2135692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.
    Bohe M; Lindström CG; Ohlsson K
    J Clin Pathol; 1987 Nov; 40(11):1345-8. PubMed ID: 3320096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution.
    Marchbank T; Chinery R; Hanby AM; Poulsom R; Elia G; Playford RJ
    Am J Pathol; 1996 Mar; 148(3):715-22. PubMed ID: 8774127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M; Passaretti S; Tittobello A; Fasani R
    Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa.
    Shibata T; Ogawa M; Matsuda K; Miyauchi K; Yamamoto T; Mori T
    Clin Chim Acta; 1986 Aug; 159(1):27-36. PubMed ID: 3638992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output.
    Sellers LA; Carroll NJ; Allen A
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):91S-95S. PubMed ID: 3080296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in stimulatory effects between rat pancreatic secretory trypsin inhibitor-61 and -56 on rat pancreas.
    Miyasaka K; Funakoshi A; Nakamura R; Kitani K; Uda K; Murata A; Ogawa M
    Jpn J Physiol; 1989; 39(6):891-9. PubMed ID: 2632901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: its hydrolysis and protection by intraluminal factors.
    Freeman TC; Davies R; Calam J
    Clin Chim Acta; 1990 Dec; 195(1-2):27-39. PubMed ID: 2093478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of misoprostol on histamine-related gastric secretion in man.
    Wilson DE; Wilson PC
    J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol inhibits gastric mucosal release of endogenous prostaglandin E2 and thromboxane B2 in healthy volunteers.
    Mertz-Nielsen A; Eskerod O; Bukhave K; Rask-Madsen J
    Gut; 1995 Apr; 36(4):511-5. PubMed ID: 7737555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new PGE1 analogue (CL115,574) III. Effects on gastric acid and mucus secretion in man.
    Wilson DE; Levendoglu H; Adams A; Ramsamooj E
    Prostaglandins; 1984 Jul; 28(1):5-11. PubMed ID: 6484216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M; Fasani R; Tittobello A
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of gastric mucus and protein secretion by cytochalasin E in rats.
    Piyachaturawat P; Suvitayawat W; Glinsukon T
    Cell Biol Int Rep; 1986 Sep; 10(9):707-16. PubMed ID: 3757065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bifunctional rat pancreatic secretory trypsin inhibitor/monitor peptide provides protection against premature activation of pancreatic juice.
    Graf R; Klauser S; Fukuoka SI; Schiesser M; Bimmler D
    Pancreatology; 2003; 3(3):195-206. PubMed ID: 12771515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.